149 related articles for article (PubMed ID: 16130142)
21. Up-regulation of CPI-17 phosphorylation in diabetic vasculature and high glucose cultured vascular smooth muscle cells.
Xie Z; Su W; Guo Z; Pang H; Post SR; Gong MC
Cardiovasc Res; 2006 Feb; 69(2):491-501. PubMed ID: 16336954
[TBL] [Abstract][Full Text] [Related]
22. Role of myosin light chain kinase and myosin light chain phosphatase in the resistance arterial myogenic response to intravascular pressure.
Cole WC; Welsh DG
Arch Biochem Biophys; 2011 Jun; 510(2):160-73. PubMed ID: 21392499
[TBL] [Abstract][Full Text] [Related]
23. Hypoxia and nitric oxide exposure promote apoptotic signaling in contractile pulmonary arterial smooth muscle but not in pulmonary epithelium.
Postolow F; Fediuk J; Nolette N; Hinton M; Dakshinamurti S
Pediatr Pulmonol; 2011 Dec; 46(12):1194-208. PubMed ID: 21618721
[TBL] [Abstract][Full Text] [Related]
24. Vascular O-GlcNAcylation augments reactivity to constrictor stimuli by prolonging phosphorylated levels of the myosin light chain.
Lima VV; Lobato NS; Filgueira FP; Webb RC; Tostes RC; Giachini FR
Braz J Med Biol Res; 2014 Oct; 47(10):826-33. PubMed ID: 25140811
[TBL] [Abstract][Full Text] [Related]
25. Regulation of basal LC20 phosphorylation by MYPT1 and CPI-17 in murine gastric antrum, gastric fundus, and proximal colon smooth muscles.
Bhetwal BP; An CL; Fisher SA; Perrino BA
Neurogastroenterol Motil; 2011 Oct; 23(10):e425-36. PubMed ID: 21883701
[TBL] [Abstract][Full Text] [Related]
26. Phosphorylation of CPI-17, an inhibitory phosphoprotein of smooth muscle myosin phosphatase, by Rho-kinase.
Koyama M; Ito M; Feng J; Seko T; Shiraki K; Takase K; Hartshorne DJ; Nakano T
FEBS Lett; 2000 Jun; 475(3):197-200. PubMed ID: 10869555
[TBL] [Abstract][Full Text] [Related]
27. Defining the structural determinants and a potential mechanism for inhibition of myosin phosphatase by the protein kinase C-potentiated inhibitor protein of 17 kDa.
Hayashi Y; Senba S; Yazawa M; Brautigan DL; Eto M
J Biol Chem; 2001 Oct; 276(43):39858-63. PubMed ID: 11517233
[TBL] [Abstract][Full Text] [Related]
28. Characterization of protein kinase pathways responsible for Ca2+ sensitization in rat ileal longitudinal smooth muscle.
Ihara E; Moffat L; Ostrander J; Walsh MP; MacDonald JA
Am J Physiol Gastrointest Liver Physiol; 2007 Oct; 293(4):G699-710. PubMed ID: 17656444
[TBL] [Abstract][Full Text] [Related]
29. Reciprocal regulation controlling the expression of CPI-17, a specific inhibitor protein for the myosin light chain phosphatase in vascular smooth muscle cells.
Kim JI; Urban M; Young GD; Eto M
Am J Physiol Cell Physiol; 2012 Jul; 303(1):C58-68. PubMed ID: 22538237
[TBL] [Abstract][Full Text] [Related]
30. Solution NMR structure of the myosin phosphatase inhibitor protein CPI-17 shows phosphorylation-induced conformational changes responsible for activation.
Ohki S; Eto M; Kariya E; Hayano T; Hayashi Y; Yazawa M; Brautigan D; Kainosho M
J Mol Biol; 2001 Dec; 314(4):839-49. PubMed ID: 11734001
[TBL] [Abstract][Full Text] [Related]
31. Ca2+-independent, inhibitory effects of cyclic adenosine 5'-monophosphate on Ca2+ regulation of phosphoinositide 3-kinase C2alpha, Rho, and myosin phosphatase in vascular smooth muscle.
Azam MA; Yoshioka K; Ohkura S; Takuwa N; Sugimoto N; Sato K; Takuwa Y
J Pharmacol Exp Ther; 2007 Feb; 320(2):907-16. PubMed ID: 17110524
[TBL] [Abstract][Full Text] [Related]
32. Ca2+-dependent rapid Ca2+ sensitization of contraction in arterial smooth muscle.
Dimopoulos GJ; Semba S; Kitazawa K; Eto M; Kitazawa T
Circ Res; 2007 Jan; 100(1):121-9. PubMed ID: 17158339
[TBL] [Abstract][Full Text] [Related]
33. Volatile anesthetics inhibit angiotensin II-induced vascular contraction by modulating myosin light chain phosphatase inhibiting protein, CPI-17 and regulatory subunit, MYPT1 phosphorylation.
Qi F; Ogawa K; Tokinaga Y; Uematsu N; Minonishi T; Hatano Y
Anesth Analg; 2009 Aug; 109(2):412-7. PubMed ID: 19608811
[TBL] [Abstract][Full Text] [Related]
34. Redox signaling and splicing dependent change in myosin phosphatase underlie early versus late changes in NO vasodilator reserve in a mouse LPS model of sepsis.
Reho JJ; Zheng X; Asico LD; Fisher SA
Am J Physiol Heart Circ Physiol; 2015 May; 308(9):H1039-50. PubMed ID: 25724497
[TBL] [Abstract][Full Text] [Related]
35. Mechanisms of Rho kinase regulation of vascular reactivity following hemorrhagic shock in rats.
Li T; Liu L; Liu J; Ming J; Xu J; Yang G; Zhang Y
Shock; 2008 Jan; 29(1):65-70. PubMed ID: 17666953
[TBL] [Abstract][Full Text] [Related]
36. Unfair competition governs the interaction of pCPI-17 with myosin phosphatase (PP1-MYPT1).
Filter JJ; Williams BC; Eto M; Shalloway D; Goldberg ML
Elife; 2017 Apr; 6():. PubMed ID: 28387646
[TBL] [Abstract][Full Text] [Related]
37. Mechanical strain increases contractile enzyme activity in cultured airway smooth muscle cells.
Smith PG; Tokui T; Ikebe M
Am J Physiol; 1995 Jun; 268(6 Pt 1):L999-1005. PubMed ID: 7611441
[TBL] [Abstract][Full Text] [Related]
38. Hypoxia inhibits myosin phosphatase in pulmonary arterial smooth muscle cells: role of Rho-kinase.
Wang Z; Lanner MC; Jin N; Swartz D; Li L; Rhoades RA
Am J Respir Cell Mol Biol; 2003 Oct; 29(4):465-71. PubMed ID: 12714374
[TBL] [Abstract][Full Text] [Related]
39. Identification of trimeric myosin phosphatase (PP1M) as a target for a novel PKC-potentiated protein phosphatase-1 inhibitory protein (CPI17) in porcine aorta smooth muscle.
Senba S; Eto M; Yazawa M
J Biochem; 1999 Feb; 125(2):354-62. PubMed ID: 9990134
[TBL] [Abstract][Full Text] [Related]
40. cGMP-dependent relaxation of smooth muscle is coupled with the change in the phosphorylation of myosin phosphatase.
Nakamura K; Koga Y; Sakai H; Homma K; Ikebe M
Circ Res; 2007 Sep; 101(7):712-22. PubMed ID: 17673671
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]